Work

P534. Initial Assessment of the Clinical Profile of the PDE10A Inhibitor MK-8189 in Patients With an Acute Episode of Schizophrenia

Year: 2022

Type: conference-abstract

Source: Biological Psychiatry

DOI: 10.1016/j.biopsych.2022.02.771

Authors: Yuki Mukai, Robert Lupinacci, Stephen Marder, Mary Mackle, Linda Snow-Adami, Tiffini Voss, Sean Smith, Michael Egan

Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), University of California, Los Angeles

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4293241927

Cites:

Cited by: 4

Related to: 10